K223405: Access Testosterone (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K223405 (Access Testosterone, cleared 2023-01-13 for Beckman Coulter, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K223405 |
| Cleared Device Trade / Generic Name | Access Testosterone |
| FDA Applicant on Filing | Beckman Coulter, Inc. |
| FDA 3-Letter Product Classification | Product Code CDZ |
| FDA Substantial Equivalence Decision Date | 2023-01-13 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Danaher Diagnostics across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Beckman Coulter, Inc., compare peer devices under FDA Product Code CDZ, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.